These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6729204)

  • 1. [Omeprazole and inhibition of gastric acid secretion].
    Rossi G
    Recenti Prog Med; 1984 Apr; 75(4):419-21. PubMed ID: 6729204
    [No Abstract]   [Full Text] [Related]  

  • 2. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.
    Clissold SP; Campoli-Richards DM
    Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Strong inhibition of gastric acid secretion: when is it justifiable?].
    Dobrilla G; Amplaz S; Benvenuti S; Bertozzo A
    G Clin Med; 1990; 71(8-9):521-6. PubMed ID: 1980653
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of acid-peptic diseases by inhibition of gastric H+,K+-ATPase.
    McArthur KE; Jensen RT; Gardner JD
    Annu Rev Med; 1986; 37():97-105. PubMed ID: 3010811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Omeprazole--a drug-blocking proton pump of the parietal cells of the stomach].
    Sosnowski M
    Pol Tyg Lek; 1985 Dec 23-30; 40(51-52):1469-72. PubMed ID: 3008128
    [No Abstract]   [Full Text] [Related]  

  • 6. Omeprazole: a comprehensive review.
    Massoomi F; Savage J; Destache CJ
    Pharmacotherapy; 1993; 13(1):46-59. PubMed ID: 8437967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Present experiences with omeprazole in the Zollinger-Ellison syndrome.
    Lamers CB
    Scand J Gastroenterol Suppl; 1986; 118():123-8. PubMed ID: 3460167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of patients with Zollinger-Ellison syndrome.
    Mignon M; Pospai D; Forestier S; Vatier J; Vallot T
    Clin Ther; 1993; 15 Suppl B():22-31. PubMed ID: 8205592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibition of H+/K+-ATPase in the parietal cell with omeprazole: a new principle of gastric acid inhibition].
    Lamers CB
    Ned Tijdschr Geneeskd; 1985 Apr; 129(15):679-82. PubMed ID: 2986019
    [No Abstract]   [Full Text] [Related]  

  • 10. [Dose-response effect of lansoprazole in patients with Zollinger-Ellison syndrome].
    Mignon M; Hochlaf S; Forestier S; Ruszniewski P; Vatier J; Joubert-Collin M
    Gastroenterol Clin Biol; 1994; 18(1):13-6. PubMed ID: 8187984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy and safety of intravenously administered pantoprazole in the treatment of gastrinoma].
    Modlin IM
    Recenti Prog Med; 2001; 92(7-8):456-61. PubMed ID: 11475787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omeprazole: effective, convenient therapy for Zollinger-Ellison syndrome.
    McArthur KE; Collen MJ; Maton PN; Cherner JA; Howard JM; Ciarleglio CA; Cornelius MJ; Jensen RT; Gardner JD
    Gastroenterology; 1985 Apr; 88(4):939-44. PubMed ID: 3972233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Omeprazole, the drug of the future for the treatment of Zollinger-Ellison syndrome and duodenal ulcer?].
    Fiasse R; Tomé G; Dive C
    Acta Gastroenterol Belg; 1984; 47(6):555-68. PubMed ID: 6537111
    [No Abstract]   [Full Text] [Related]  

  • 14. Omeprazole in the Zollinger-Ellison syndrome.
    Bardram L; Stadil F
    Scand J Gastroenterol; 1986 Apr; 21(3):374-8. PubMed ID: 3715402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gastric secretory, ultrastructural and pH changes during prolonged treatment with omeprazole in a severe form of Zollinger-Ellison syndrome].
    Mignon M; Alcabes G; Lehy T; Nguyen Phuoc BK; Vatier J; Bonfils S
    Gastroenterol Clin Biol; 1984 Dec; 8(12):947-54. PubMed ID: 6519403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Omeprazole: effects and side effects].
    Hengels KJ
    Z Gastroenterol; 1984 May; 22(5):241-3. PubMed ID: 6741201
    [No Abstract]   [Full Text] [Related]  

  • 17. [Omeprazole. A new substance for inhibiting acid production].
    Uhl D
    Med Monatsschr Pharm; 1990 Feb; 13(2):34-7. PubMed ID: 2179691
    [No Abstract]   [Full Text] [Related]  

  • 18. Is there a need for strong gastric acid inhibition in clinical practice?
    Lamers CB
    Digestion; 1989; 44 Suppl 1():4-8. PubMed ID: 2691309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Suppression of acid secretion and plasma level of a once-daily dose of omeprazole].
    Müller P; Seitz HK; Simon B; Dammann HG
    Arzneimittelforschung; 1983; 33(12):1685-6. PubMed ID: 6686775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibitors of proton pump in the treatment of Zollinger-Ellison syndrome].
    Kubyshkin VA; Kochatkov AV
    Khirurgiia (Mosk); 2012; (12):67-71. PubMed ID: 23323285
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.